By my reckoning they have five valuable assets that are all ready to monetise:-
Vivagel
Viraleze
DEP Cabazitaxel
DEP Docetaxel
DEP Irinotecan
If management cannot get some sort of deal from one of the above then they do not deserve to continue with a capital raise bailout. The last one was for $1.50, remember, and where has all that money gone?
I will not support a CR until some deals have been struck and the SP has recovered.
Ann: Investor Webinar Notification - SPL Business Update, page-15
-
- There are more pages in this discussion • 30 more messages in this thread...
You’re viewing a single post only. To view the entire thread just sign in or Join Now (FREE)
Add SPL (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
9.2¢ |
Change
-0.001(1.08%) |
Mkt cap ! $38.39M | |||
| Open | High | Low | Value | Volume |
| 9.2¢ | 9.3¢ | 9.1¢ | $210.6K | 2.290M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 1 | 467139 | 9.2¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 9.4¢ | 152000 | 2 |
View Market Depth
| Last trade - 16.10pm 18/10/2024 (20 minute delay) ? |
| SPL (ASX) Chart |